Cancer 2:Oncogenes and tumour supressor genes Flashcards
What is the cancer cell phenotype (hallmarks of cancer)
- Disregards signal to stop proliferating
- Disregards signals to differntiate
- Capacity for sustained proliferation
- Evasion of apoptosis
- Ability to invade
- Ability to promote angiogenesis
State the cell cycle and the amount of time in each
G1- 10hrs
S- 7.5hrs
G2- 3.5hrs
M=1hrs
How long does the cell cycle occur for
22hrs
What is the purpose of cycle checkpoints
growth arrest ensures genetic fidelity
What are the cycel checkpoint
After G1:
check for cell size/favourable environmental factors
check for DNA damage
After S: none
After G2: check for damaged/unduplicated DNA, check for unduplicated centrosomes
After metaphase of M: check for chromosome attachment to the mitotic spindle
Which proteins are accumulated and destroyed during the cell cycle
Cyclins, cycle dependent kinases, cycle dependent kinase inhibitors
What drives a cell through a checkpoint
Permanent activation of a cyclin can drive a cell through a checkpoint.
What are proto-oncogenes
code for essential proteins involved in maintenance of cell growth, division and differentiation.
What is the difference between proto-oncogene and oncogene
following a mutation (1 can be enough!), the protein product no longer responds to control influences
What can be abnormal about an oncogene
aberrantly expressed, over-expressed or aberrantly active.
Outline the methods of oncogene actiation
- Mutation in coding sequence (point mutation)
- Gene amplificatin (multiple gene copies i.e. too much proto-oncogene)
- Chromosomal translication (chimaeric genes)
- Insertional mutagenesis (viral infection)
By what mechanism does oncogene activation then cause abnormal protein activity
- Mutation in coding sequence (point mutation) –> ABERRANTLY ACTIVE PROTEIN
- Gene amplificatin (multiple gene copies) –> OVERPRODUCTION OF NORMAL PROTEIN
- Chromosomal translication (chimaeric genes)
- Insertional mutagenesis (viral infection)
3/4 CAN LEAD TO: STRONG ENHANCER (increases normal protein level e.g. burkitt's lymphoma) ... strong enhancer from another chromosome during fusion which increaes expression of the protein
or
FUSION TO ACTIVELY TRNASCRIBED GENE OVERPRODUCES PROTEIN OR FUSION PROTEIN IS HYPERACTIVE (e.g Philadelphia chromosome)
What is the philalphia chromsome
Chr 9 ABL switches with the short arm on 22
left behind: 9q+, Ph22q- (with BCR-ABL)
BCR-ABL is powerfullt expressed…. few situations where a SINGLE DNA CHANGING event can cause cancer
How are signal transduction proteins relvant in cancer
Proteins involved in signal transduction are potential critical gene targets (proto-oncogenes)
Give types of receptors which could be protooncogenes
Nuclear/cytosolic receptor
Tyrosin kinase receptor
G-protein coupled receptor
How does each signal transduction protein affect proliferation
Nuclear/cytosolic receptor: (imapcts transcription/translation–> proliferation)
Tyrosine kinase (phosphorlation cascade–> proliferation)
GPCR: (activates kinase casade–> phosphoryation cascade–> proliferation)
Give examples of proteins in each of the proto-oncogenes
Tyrosine: membrane: met (heptaocyte growth factor receptor), neu (HER2), inside membrane src, ret
GPCR: membrane: ras, gip-2, inside membrane: raf, pim 1 (confused as I thought ras and raf was tyrosine kinase)
Intraacellular: myc, fos, jun
What does RAS do
Ras (on the membrane)
Binds GTP, activating it. This then activates RAF. (inside of membrane) to cause signalling cascade which increases proliferation
Dephosphorylation of the GTP to GDP switches RAS off.
RAF will stop
How can RAS go wrong
Mutant RAS fails to dephosphorylate GTP and remains active.
This then keeps on stimulating RAF and thus proliferation
How does RAS and RAF work
Ligand binds receptor (e.g. tyrosine kinase)
RAS is tethered to the membrane.
RAS binding GTP will then allow it to bind RAF, activating it.
Dephopsorylation will cause the RAF to dissocaite
Why can damage to a single proto-oncogene, not both of the genes, cause cancer
Because it is now damaged.
Having a normal proto-oncogene will not then remove the activty of the oncogene